CT

BPI 2026 · Biotech

ClearB Therapeutics at BPI 2026

ClearB Therapeutics brings 2 presentations to BPI 2026 in Boston. Its sessions focus on external manufacturing and on preparing processes for large-scale production. One covers the regulatory complexities a hepatitis B drug developer meets when working with outside manufacturers.

OrganizationBPI 2026 Attendance
CT
ClearB Therapeutics
1 Chief Technology Officer
Biotech
Drug developer working on therapies for chronic hepatitis B.
Talk
Fri Sep 25
2:00pm–2:30pm
Navigating regulatory complexities in external manufacturing
CDMO Partnering & External Manufacturing
Talk
Fri Sep 25
3:00pm–3:30pm
PANEL DISCUSSION: Strategies to Future-Proof Manufacturing Processes for Large-Scale Production
CMC Strategy & Manufacturing Performance · with University College Cork, Third Arc Bio, Gyros Protein Technologies +1 more

Explore the full BPI 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full BPI 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from ClearB Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction